Skip to content

Rich Pharmaceuticals, Inc.: 10-Q filed 2017-02-13

What Rich Pharmaceuticals, Inc. reported in its quarterly report filed 2017-02-13 (fiscal Q3 2017): 22 published measures, 50 facts as tagged in accession 0001662252-17-000023.

This filing

Form
10-Q (quarterly report)
Filed
2017-02-13
Fiscal period
fiscal Q3 2017
Accession
0001662252-17-000023 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Rich Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-12-312,437USD
At 2016-03-316,531USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-12-313,207,538USD
At 2016-03-312,398,233USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-12-31-3,205,101USD
At 2016-03-31-2,391,702USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-540,450USD92
2016-04-01 to 2016-12-31-985,332USD275
2015-10-01 to 2015-12-31-900,723USD92
2015-04-01 to 2015-12-31-1,857,689USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-04-01 to 2016-12-31-288,931USD275
2015-04-01 to 2015-12-31-343,012USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-04-01 to 2016-12-31288,931USD275
2015-04-01 to 2015-12-31331,597USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-04-01 to 2015-12-31-1,054USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-12-31-10,188,773USD
At 2016-03-31-9,203,440USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-12-312,437USD
At 2016-03-313,731USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-12-31198,128USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-208,816USD92
2016-04-01 to 2016-12-31-607,088USD275
2015-10-01 to 2015-12-31-298,595USD92
2015-04-01 to 2015-12-31-859,036USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-03-312,800USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-10-01 to 2016-12-31-43,715USD92
2016-04-01 to 2016-12-31-186,189USD275
2015-10-01 to 2015-12-31-19,872USD92
2015-04-01 to 2015-12-31-40,127USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-12-313,207,538USD
At 2016-03-312,398,233USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-12-31366,564USD
At 2016-03-311,139,431USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-10-01 to 2016-12-31208,816USD92
2016-04-01 to 2016-12-31607,088USD275
2015-10-01 to 2015-12-31298,595USD92
2015-04-01 to 2015-12-31859,036USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-12-319,000USD275

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-12-315,670,271USD
At 2016-03-316,589,374USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-12-31896,614USD
At 2016-03-31530,150USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-03-312,800USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-10-01 to 2016-12-31431USD92
2016-04-01 to 2016-12-311,293USD275
2015-04-01 to 2016-03-31799USD366
2015-10-01 to 2015-12-31206USD92
2015-04-01 to 2015-12-31443USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-12-31127,133USD275
2015-04-01 to 2015-12-3170,247USD275

Inspect the source

Entity
Rich Pharmaceuticals, Inc. / CIK 0001504389
Captured
SEC response SHA-256
915b548928758b0cd7825b62d7fc36ff2ecd50f0e88985055b0b19ae94428b67

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001504389.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))